PROS1 and cancer: Given the fact that Pin1 promotes cancer development through activating more than 40 oncogenes/growth-promoting proteins and inactivating over 20 tumor suppressors [21], sorafenib induced Pin1 down-regulation might in part account for its multiple targeting effect in HCC.